Healthtech Investors & VC Firms in North America
2650 firms in this list, with a median first check of $500K. 645 of them lead rounds. Generated from verified public data and updated continuously.
Grishin Robotics
Silicon ValleySeed–Series A$250K – $1M
24 people
Kaiser Permanente Ventures
San FranciscoSeed–Growth$2M – $5M
9 people
Smash Capital
New YorkSeries C–Growth
24 people
Synchrony Ventures
San FranciscoSeed–Series A
36 people
Version One Ventures
VancouverPre-Seed–Seed$250K – $500K
3 people
Commonweal Ventures
New YorkPre-Seed–Seed$500K – $2.5M
20 people
Trilogy Equity Partners
SeattleSeed–Series A$2M – $6M
17 people
FCA Venture Partners
NashvilleSeed–Series B$500K – $10M
13 people
Mercato Partners
Salt Lake CityGrowth–Late Stage
22 people
The Argentum Group
New YorkGrowth–Late Stage
10 people
White Oak Global Advisors
San FranciscoLate Stage
37 people
Bay City Capital
San RafaelSeed–Late Stage$5M – $10M
8 people
ZAKA VC
San FranciscoPre-Seed–Seed
11 people
Stout Street Capital
DenverPre-Seed–Series A$250K
6 people
Think+ Ventures Management, Llc
Palo AltoSeed–Series A$200K – $500K
12 people
Aegis Ventures
New YorkSeed–Series A
35 people
FoundersX
Palo AltoPre-Seed–Series A
14 people
Seaport Capital
New YorkSeed–Late Stage$10M – $40M
17 people
Ossian Capital
Miami
1 person
Brewer Lane Ventures
BostonSeries A
22 people
Excelerate Health Ventures
Research Triangle ParkSeed–Series A
30 people
PEGASUS CAPITAL
StamfordGrowth
27 people
Svoboda Capital Partners
ChicagoGrowth$10M – $25M
21 people
Aquiline Technology Growth
New YorkGrowth
2 people
Related lists
Investors & VC Firms in North America (13488)Investors & VC Firms in United States (12527)Investors & VC Firms in Europe (5831)Investors & VC Firms in Global (4707)AI & Machine Learning Investors & VC Firms (4538)Fintech Investors & VC Firms (4530)SaaS Investors & VC Firms (4205)Healthtech Investors & VC Firms (4177)Enterprise Software Investors & VC Firms (4092)Crypto & Web3 Investors & VC Firms (3961)
Data sourced from public filings and firms' own websites — see our methodology.



































































































